Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06276348 · ClinicalTrials.gov registry record · NA
Newborn Genomic Sequencing Pilot Study
A NA study, sponsored by Rady Pediatric Genomics & Systems Medicine Institute.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT06276348 is a NA study that has completed, run by Rady Pediatric Genomics & Systems Medicine Institute. The registered enrollment target is 120 participants.
The verdict
NCT06276348, a NA study, has completed, sponsored by Rady Pediatric Genomics & Systems Medicine Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test a new method for newborn screening using whole genome sequencing, called BeginNGS. Newborns who are not suspected of having genetic diseases and who are admitted to the NICU at Rady Children's Hospital, San Diego, will be enrolled. The main questions this study aims to answer are: * What is the diagnostic yield of diagnostic whole genome sequencing (DWGS) in this population? * What is the diagnostic sensitivity and specificity of BeginNGS and whole exome sequencing (WES) as compared to DWGS? * What are the potential issues related to implementing DWGS in this population? Enrolled newborns will have a blood sample taken and will receive three tests: * DWGS * BeginNGS * WES
Interventions
- GENETIC Whole genome sequencing
- GENETIC BeginNGS test
- GENETIC WES
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2024-11-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06276348
The ClinicalTrials.gov registry entry for NCT06276348 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rady Pediatric Genomics & Systems Medicine Institute, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Whole genome sequencing is the first listed.
NCT06276348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06276348 about?
NCT06276348 is a clinical study titled "Newborn Genomic Sequencing Pilot Study". The goal of this clinical trial is to test a new method for newborn screening using whole genome sequencing, called BeginNGS. Newborns who are not suspected of having genetic diseases and who are admitted to the NICU at Rady Children's Hospital, San Diego, will be enrolled. The main questions this s...
What is the current status of trial NCT06276348?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2023-03-13. Estimated completion is 2024-11-12.
What interventions are being tested in trial NCT06276348?
The interventions under investigation include: Whole genome sequencing (GENETIC), BeginNGS test (GENETIC), WES (GENETIC).
Who is sponsoring clinical trial NCT06276348?
This trial is sponsored by Rady Pediatric Genomics & Systems Medicine Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.